Development and validation of a GC/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood

Journal of Pharmaceutical and Biomedical Analysis

Volumn 102, Issue , 2014, Pages 25-32

  Nikolaou, Panagiota ^a   Papoutsis, Ioannis ^a   Dona, Artemisia ^a   Spiliopoulou, Chara ^a   Athanaselis, Sotiris ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antiepileptics; Blood; GC MS; Lamotrigine; Levetiracetam

Indexed keywords

ETIRACETAM; LAMOTRIGINE; ANTICONVULSIVE AGENT; PIRACETAM; TRIAZINE DERIVATIVE;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; FORENSIC MEDICINE; HUMAN; LIMIT OF DETECTION; MALE; MASS FRAGMENTOGRAPHY; SOLID PHASE EXTRACTION; ANALOGS AND DERIVATIVES; BLOOD; DRUG MONITORING; MIDDLE AGED; PROCEDURES; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG MONITORING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; PIRACETAM; SOLID PHASE EXTRACTION; TRIAZINES; YOUNG ADULT;

EID: 84907513310     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.08.034     Document Type: Article

References (30)

1. Brunetto M.R., Contreras Y., Delgado Y., Gallignani M., Estela J.M., Martin V.C. Development and validation of a rapid column-switching high-performance liquid chromatographic method for the determination of lamotrigine in human serum. J. Chromatogr. Sci. 2009, 47:478-484.
2. Jain D.S., Subbaiah G., Sanyal M., Pal U., Shrivastav P.S. Determination of levetiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to bioequivalence studies. Rapid Commun. Mass Spectrom. 2006, 20:2539-2547.
3. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol. Ther. 2000, 85:77-85.
4. Pucci V., Bugamelli F., Mandrioli R., Ferranti A., Kenndler E., Raggi M.A. High-performance liquid chromatographic determination of levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed. Chromatogr. 2004, 18:37-44.
5. Blonk M.I., Van der Nagel B.C., Smit L.S., Mathot R.A.A. Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878:675-681.
6. French J. Use of levetiracetam in special populations. Epilepsia 2001, 42:40-43.
7. Boon P., Chauvel P., Pohlmann-Eden B., Otoul C., Wroe S. Dose-response effect of levetiracetam 1000 and 2000mg/day in partial epilepsy. Epilepsy Res. 2002, 48:77-89.
8. Greiner-Sosanko E., Giannoutsos S., Lower D.R., Virji M.A., Krasowski M.D. Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam. J. Chromatogr. Sci. 2007, 45:616-622.
9. Juenke J.E.M., Brown P.I., Johnson-Davis K.L., McMillin G.A. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection. Ther. Drug Monit. 2011, 33:209-213.
10. Patsalos P.N. Clinical pharmacokinetics of levetiracetam. Clin. Pharmacokinet. 2004, 43:707-724.
11. Radtke R. Pharmacokinetics of levetiracetam. Epilepsia 2001, 42:24-27.
12. El-Enany N.M., El-Sherbiny D.T., Abdelal A.A., Belal F.F. Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde. J. Fluoresc. 2010, 20:463-472.
13. Greiner C., Haen E. Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD). J. Chromatogr. B 2007, 854:338-344.
14. Castel-Branco M.M., Almeida A.M., Falcao A.C., Macedo T.A., Caramona M.M., Lopez F.G. Lamotrigine analysis in blood and brain by high-performance liquid chromatography. J. Chromatogr. B 2001, 755:119-127.
15. Barbosa N.R., Midio A.F. Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma. J. Chromatogr. B 2000, 741:289-293.
16. Zufia L., Aldaz A., Ibanez N., Viteri C. LC method for the therapeutic drug monitoring of lamotrigine: evaluation of the assay performance and validation of its application in the routine area. J. Pharm. Biomed. Anal. 2009, 49:547-553.
17. Croci D., Salmaggi A., Grazia U., Bernardi G. New high-performance liquid chromatographic method for plasma/serum analysis of lamotrigine. Ther. Drug Monit. 2001, 23:665-668.
18. Mayo Clinic, Mayo Medical Laboratories. Test ID: LAMO. Lamotrigine, Serum. Available at: (Accessed 24.07.2014). http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/80999.
19. Watelle M., Demedts P., Franck F., De Deyn P.P., Waters A., Neels H. Analysis of the antiepileptic phenyltriazine compound lamotrigine using gas chromatography with nitrogen phosphorus detection. Ther. Drug Monit. 1997, 19:460-464.
20. Hallbach J., Vogel H., Guder W.G. Determination of lamotrigine, carbamazepine and carbamazepine epoxide in human serum by gas chromatography mass spectrometry. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35(10):755-759.
21. Isoherranen N., Roeder M., Soback S., Yagen B., Schurig V., Bialer M. Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection. J. Chromatogr. B 2000, 745:325-332.
22. Martens-Lobenhoffer J., Bode-Boger S.M. Determination of levetiracetam in human plasma with minimal sample pretreatment. J. Chromatogr. B 2005, 819:197-200.
23. Croci D., Salmaggi A., de Grazia U., Bernardi G. New high-performance liquid chromatographic method for plasma/serum analysis of lamotrigine. Ther. Drug Monit. 2001, 23:665-668.
24. Greiner C., Haen E. Development of a simple column-switching high performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD). J. Chromatogr. B 2007, 854:338-344.
25. Antonilli L., Brusadin V., Filipponi F., Guglielmi R., Nencini P. Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma. J. Pharm. Biomed. Anal. 2011, 56:763-770.
26. Kim K.B., Seo K.A., Kim S.E., Bae S.K., Kim D.H., Shin J.G. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. J. Pharm. Biomed. Anal. 2011, 56:771-777.
27. Luo W., Kong S.T., Yang S., Chan B.C., Ho P.C. A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS. Bioanalysis 2013, 5(15):1843-1851.
28. Hotha K.K., Kumar S.S., Bharathi D.V., Venkateswarulu V. Rapid and sensitive LC-MS/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study. Biomed. Chromatogr. 2012, 26:491-496.
29. Food and Drug Administration (FDA) Guidance for Industry, Bioanalytical Method Validation May 2001.
30. International Conference on Harmonization (ICH) of Technical requirements for Registration of Pharmaceuticals for Human Use: Harmonized Tripartite Guideline on Validation of Analytical Procedures: Text and Methodology Q2 (R1), Step 4 November 2005, ICH Steering Committee, Published by IFPMA, Switzerland.